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Chronic pain can impact on sleep but the extent and nature of sleep problems in patients 
with chronic pain are incompletely clear. Several validated tools are available for sleep 
assessment but they each capture different aspects. We aimed to describe the extent of 
sleep issues in patients with chronic non-malignant pain using three different validated 
sleep assessment tools and to determine the relationship of sleep issues with pain 
severity recorded using the Brief Pain Inventory (BPI), a commonly used self-assessment 
tool in pain clinics. The BPI has a single question on the interference of pain on sleep and 
we also compared this with the validated sleep tools. 
Design 
Prospective, cross-sectional study.  
Setting 
Pain management clinic at a large teaching hospital in the UK. 
Subjects  
Adult patients (with chronic non-malignant pain of at least 3 months’ duration) attending 
clinic during a 2 month period. 
Methods  
Participants completed the Pittsburgh Sleep Quality Index, the Pain and Sleep 
Questionnaire-3 and the Verran Snyder- Halpern sleep scale, plus the BPI. Duration and 
type of pain, current medications and demographic data were recorded. 
Results: 
We recruited 51 patients and 82% had poor sleep quality as shown by PSQI scores 
above 5. PSQI (p=0.0002), PSQ-3 (p=0.0032), VSH sleep efficiency (p=0.012), sleep 
disturbance (p=0.0014) and waking after sleep onset (p=0.0005) scores were 
associated with worse BPI pain scores. BPI sleep interference scores concurred broadly 
with the validated sleep tools. Median [range] sleep duration was 5.5 [3.0-10.0] hours 
and was also related to pain score (p=0.0032).  
Conclusion  
Chronic pain has a marked impact on sleep regardless of the assessment tool used. The 
sleep interference question in the BPI could be used routinely for initial identification of 







Sleep is a behaviourally regulated drive which is vital for maintaining physiological 
functioning (1).  Issues with sleep are perhaps one of the most common complaints of 
chronic pain patients, and are known to contribute to the severity and maintenance of 
chronic pain symptoms. Both pain and sleep are major health problems worldwide, and 
an interaction between them can lead to impairment in biological functioning and 
behaviour (1,2). In a large survey, 50% chronic pain patients reported feeling tired all 
the time (3). Experimental studies and cross-sectional surveys have suggested that the 
relationship between sleep disturbances and pain could be reciprocal, in which pain 
disturbs sleep quality and latency, and poor sleep exacerbates pain (1). Few identified 
risk factors are modifiable, and sleep has been identified as one of the modifiable risk 
factors.  It is clear that there is an association between chronic pain and poor sleep 
(4,5), but the extent and nature of sleep quality issues in patients with chronic pain and 
the relationship between pain severity and sleep problems is less clear.  
There are several dedicated sleep assessment tools available for the evaluation of sleep 
parameters and each provides information on different aspects of sleep over different 
time periods. In this prospective clinical study, our aim was to investigate the extent and 
nature of sleep issues in patients with chronic pain and the relationship between sleep 
parameters and pain severity in our patients, using three different sleep assessment 
tools. The commonly used pain questionnaire, the Brief Pain Inventory (BPI), 
recommended by the Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials (IMMPACT) group, has only one question on sleep in the section on 
interference (6,7). We also investigated the utility of this single question on sleep 
interference in the BPI to reflect the findings of the three dedicated sleep assessment 




This was a prospective cross-sectional study of self-reported sleep quality in patients 
with chronic pain who were attending a chronic pain management clinic. We aimed to 
investigate the extent and nature of sleep issues in a local population of patients with 




Three different sleep assessment tools were used; each of these provides information on 
a different aspect of sleep issues and their duration. The Pittsburgh Sleep Quality Index 
(PSQI) is a 19-item self-report questionnaire used for the assessment of sleep quality 
over the last month, with a overall global score above 5 indicating poor quality of sleep; 
sleep duration is also captured. The Pain and Sleep Questionnaire-3 (PSQ-3) evaluates 
the impact of pain on sleep over the previous week. It is an abbreviated version of the 
original PSQ and focuses specifically on sleep issues related to pain. Three visual 
analogue scales (VAS) are used, with one end of the scale being bounded by “never” and 
the other by “always”. A score for each component (falling asleep, awakening during the 
night and awakening in the morning) is determined by measuring the scale from the left 
end of the line, and an algebraic sum is then calculated to give a score of 0-300. A 
higher score indicates a greater level of sleep disturbance due to pain. The PSQ-3 has 
been psychometrically tested for its reliability and validity (8). The Verran Snyder-
Halpern (VSH) scale considers sleep in the last 24h and uses VAS to answer 15 questions 
to evaluate sleep parameters in three different domains: sleep disturbance, sleep 
efficiency and sleep supplementation (9). Latency and wake after sleep onset is also 
captured. Each question is scored from 0 to 100, with 0 indicating the sleep behaviour or 
quality is not present and 100 indicating that it is consistently experienced. Reverse 




The Brief Pain Inventory (BPI) is a well validated self-assessment tool used for chronic 
pain patients, requiring patients to rate their pain and the level of interference of pain 
with activities and sleep on a scale of 0 to 10. Its reliability and validity has been shown 
for use in both cancer pain and non-malignant chronic pain, and it has been translated 
into multiple languages for use worldwide (4). It is recommended by the Initiative on 
Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) group, and 
has a single question on the interference of pain on sleep. We also aimed to assess the 
utility of the single sleep question in the BPI compared to the three dedicated sleep 
assessment tools and its association with the severity of pain.  
 
Ethical approval for this study was obtained from the Leicester South Research Ethics 
Committee (reference number 16/EM/04) and written informed consent was obtained 
from all participants before the study. 
 
Recruitment 
All patients scheduled to attend the pain clinic during the recruitment period were sent 
an invitation letter and participant information sheet by the clinical care team in advance 
of their appointment. Any patient with chronic non-malignant pain of at least 3 months’ 
duration and who expressed an interest in taking part was screened by the healthcare 
team for eligibility. The inclusion criteria were as broad as possible: age over 16, able to 
give written, informed consent and neurologically stable enough to report on health and 
pain status. Patients were excluded if they had insufficient English to be able to 
understand what was required of them. A formal sample size calculation was not 
performed due to the absence of pre-existing data, but we aimed to recruit around 50 
patients in a fixed recruitment period of 2 months and each patient completed the sleep 
assessments on a single occasion. The CONSORT diagram (Figure 1) summarises 
recruitment. Of the 90 patients not recruited, 35 declined to participate, 43 had 
conflicting clinic appointment issues, 3 were not eligible and a researcher was not 




CONSORT diagram showing recruitment. 
 
Study data 
Sleep parameters were assessed using three sleep assessment tools: the Pittsburgh 
Sleep Quality Index (PSQI) to assess sleep over the previous month (7); the Pain and 
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Sleep Questionnaire 3 Item Index (PSQ-3) to assess sleep related to pain over the 
previous week (8) and the Verran Snyder-Halpern (VSH)  sleep scale to assess sleep 
over the previous 24-hour period (9). Each sleep assessment tool was completed once 
by each patient after the clinic visit during a one-to-one session with a researcher. The 
BPI was also completed at the same time (4). Basic demographic information was 
collected from medical notes and included age, sex, chronic pain duration, chronic pain 
type and diagnosis, and current medications.  
Data Management and Statistical Analysis 
Data was collected using a paper-based case record form. Scores were calculated 
independently by two researchers and cross-checked to minimise errors then transcribed 
into Microsoft Excel, with further analysis. Statistical analysis was undertaken using 
Analyse-It add-in for Excel. None of the data were normally distributed and all data are 
presented as median [range]. BPI average pain and sleep interference scores were 
divided into a convenience grouping of tertiles: mild: scores of 4 or less, moderate: 5-6 
and severe: scores of 7 or over. Data in relation to these tertile groupings were analysed 
using Kruskal-Wallis testing. Correlations were undertaken using Spearman. A p-value of 
<0.05 was considered to be statistically significant.  
Results: 
 
The total number of patients invited to take part was 141.  Of these, 51 participants 
were recruited and there were no withdrawals after consenting. The reasons for non-
participation are shown in Figure 1. Baseline data are shown in Table 1. The majority of 
the participants were female (n=37, 73%). The median [range] age was 53 [18-88] 
years and the median duration of chronic pain was 6 [1.8-33] years. Twenty-three 
(45.2%) participants were taking simple analgesia, 19 (37.3%) were taking opioids and 
16 (31.4%) were taking neuropathic painkillers at the time of the study (Table 1).  
Sleep assessment 
The average pain and sleep interference scores from BPI and the other sleep assessment 
tools are shown in Table 2. The overall median [range] pain score from the BPI was 6 
[0-10] whilst the sleep interference score was 8 [0-10]. There was a significant 
correlation between average pain and sleep interference scores (p<0.0001). The BPI 
average pain and sleep interference scores were grouped into convenience tertiles of 4 
or less for mild pain/sleep interference, 5-6 for moderate pain/sleep interference and 7 
or more for severe pain/sleep interference. Thirteen participants scored their average 
pain as mild, 16 as moderate and 22 as severe. In terms of sleep interference, 15 
participants gave a score equating to mild, 7 as moderate and 29 as severe interference 
with sleep.  
PSQI and PSQ-3 scores are presented in Table 2; 41 (80%) of participants had a total 
PSQI score over 5, indicating poor sleep quality and 39 (76.5%) had a PSQ-3 score 
above 75. Median [range] sleep duration captured by the PSQI was 5.5 [3.0-10.0] 
hours, with 37 (72.5%) of participants reporting sleeping 6h or less. Total PSQI scores 
were associated with BPI average pain score tertiles (p=0.0002, Figure 2A) with higher 
scores seen in those with higher pain scores. Sleep duration decreased (p=0.0002, 























Scores from the three overall domains of the VSH tool are shown in Table 2. A third of 
patients had disturbance scores over 500, 35% had WASO scores of >60 and 57% had 
efficiency scores of <250; 13 patients (25%) had disturbance scores >500, plus WASO 
scores >60 and efficiency scores <250. VSH sleep disturbance, efficiency and WASO 
were significantly associated with BPI average pain scores with increasing disturbance 
(p=0.0014, Figure 3A), decreasing efficiency (p=0.012, Figure 3B) and increasing WASO 
(p=0.0005, Figure 5C) across severity tertiles. In terms of sleep latency (the time taken 
to fall asleep), 22 (43%) of participants had scores above the 75th percentile but latency 
did not significantly increase across average pain severity or sleep interference score 
tertile (Table 2).  
 
There was a concurrence between the BPI sleep interference score tertiles and the sleep 
assessment scores: total PSQI score increased (p<0.0001, Figure 4A), PSQI sleep 
Figure 2 
 
A. PSQI total quality score, B PSQI 
sleep duration and C. PSQ-3 score by 
BPI average pain score tertile. Data 
shown as median, interquartile and 
full range with individual data points 
overlaid. BPI sleep interference score 
tertiles: mild = 0-4, moderate = 5 or 
6 and severe = 7-10. P values shown 
are from Kruskal-Wallis analysis. 
Figure 3 
 
A. VSH sleep disturbance score, B VSH 
sleep efficiency score and C. VSH wake 
after sleep onset (WASO) score by BPI 
average pain score tertile. Data shown 
as median, interquartile and full range 
with individual data points overlaid. BPI 
average sleep interference tertiles: mild 
= 0-4, moderate = 5 or 6 and severe = 





duration decreased (p=0.0012, Figure 4B) and PSQ-3 score increased (p=0.0022, Figure 
4C) as BPI sleep interference scores increased. Likewise VSH disturbance was 
significantly increased (p=0.0001, Figure 5A), efficiency decreased (p=0.019, Figure 5B) 
and WASO increased (p=0.002, Figure 5C) across BPI sleep interference score tertiles.  
 
 Figure 4 
A. PSQI total quality score, B. PSQI 
sleep duration and C. PSQ-3 score 
by BPI sleep interference score 
tertile. Data shown as median, 
interquartile and full range with 
individual data points overlaid. BPI 
sleep interference score tertiles: 
mild = 0-4, moderate = 5 or 6 and 
severe = 7-10. P values shown are 
from Kruskal-Wallis analysis. 
 
Figure 5 
A. VSH sleep disturbance score, B. 
VSH sleep efficiency score and C. 
VSH wake after sleep onset (WASO) 
score by BPI sleep interference 
score tertile. Data shown as 
median, interquartile and full range 
with individual data points overlaid. 
BPI average sleep interference 
tertiles: mild = 0-4, moderate = 5 
or 6 and severe = 7-10. P values 






The main aim of the study was to assess the extent and nature of sleep issues and the 
association with pain severity in patients with chronic pain patients using three different 
sleep assessment tools. In addition, since the BPI is routinely used, well validated (4) 
and familiar to patients and clinicians alike, we  investigated how well the single question 
on pain interference with sleep in the BPI was able to identify sleep problems and 
whether it concurred with results from three dedicated sleep assessment tools. We found 
poor overall sleep quality in 80% of patients, short sleep duration, marked sleep 
disturbance and waking and low sleep efficiency, with a significant effect of pain severity 
on these measures. Latency was an issue for almost half the participants but was not 
related to pain scores. BPI sleep interference scores concurred with the more complex 
validated sleep assessment tools and were also associated with severity of pain. This 
suggests that the BPI sleep interference question could be used routinely for initial 
identification of sleep problems in patients with chronic pain.  
We used three different validated self-reported sleep assessment tools to identify sleep 
issues in our patients. The PSQI is one of the most widely used methods for the 
assessment of sleep and has been used in multiple settings (5,7,10). It was found that 
there was moderate to high evidence reported for sufficient structural validity and low to 
high evidence for sufficient internal consistency and sufficient reliability (9). A very 
recent systematic review reported that the PSQI was one of three most commonly used 
patient reported outcome measures for assessing sleep quality in adult patients with 
chronic pain conditions (12). The PSQI describes a wide array of sleep problems but does 
not directly assess the impact of pain on sleep. In a study of people with chronic non-
malignant pain, it was reported that poor sleep quality identified by the PSQI was 
associated with low pain tolerance on the cold pressor pain task (12). We found that 
around 80% of our participants had a PSQI score above 5, indicating poor sleep quality, 
concurring with a recent systematic review (5). The PSQI sleep quality score was higher 
as BPI average pain score increased indicating that poor sleep quality was related to pain 
severity. We also found sleep duration of as low as 3 hours/night (median 5.5 h) in some 
participants and >70% slept for 6h or less; sleep duration decreased as BPI pain 
intensity score increased. Other studies have not reported the sleep duration component 
of the PSQI. The PSQ-3 scale specifically captures effects of pain on sleep. We found 
here that the PSQ-3 scores were above the 75th percentile in more than 72% of 
participants, concurred with BPI sleep interference scores and were worse in those with 
more severe pain. 
 
The VSH scale was originally developed to assess the subjective sleep quality of 
hospitalised patients but has been used in a variety of populations, including healthy 
adults, adults with insomnia, hospitalised patients and healthy adults given melatonin 
(9,13-15). High scores for sleep disturbance were common in our patients with more 
than half of participants having a disturbance score of >350 out of 700 and 38% with a 
score of 500 or more, indicating profound sleep disturbance. In healthy subjects, VSH 
disturbance scores are reported to be around 100-200 (14,15). Conversely, more than 
60% of our participants had an efficiency score of <300 out of 600, and nearly one 
quarter (n=12) had a score of <150. Again, these scores are considerably lower than in 
people without chronic pain (14,15). Both sleep disturbance and efficiency scores 
reflected BPI pain scores such that disturbance scores increased and efficiency scores 
decreased as pain was more severe. As part of the disturbance domain, a score for 
WASO is captured; again this was strongly associated with pain severity, such that 
participants with higher pain scores were awake more than those with less severe pain. 
Sleep latency was a problem for many patients but was not significantly associated with 
pain scores.  
We found a marked impact of pain on and the BPI sleep interference question, and good 
concurrence between this and the dedicated sleep assessment tools, suggesting that BPI 




It should be noted that all the self-reporting assessment tools used here are subjective; 
the gold standard method for objective assessment of sleep is polysomnography (6) but 
this is impractical for routine clinical use and results can be affected by medication. 
Future studies could include the use of actigraphy to objectively measure sleep 
parameters; this has good agreement with polysomnography (16). Wrist worn 
actigraphy ‘watches’ capture sleep onset and duration, latency and disturbance and also 
allow pain scores to be inputted contemporaneously; these have been successfully used 
in the context of clinical trials and broadly concur with subjective scores such as VSH 
(17).  
 
This was a small observational study restricted to a local population of patients. 
Nevertheless, we clearly show here that sleep issues are widespread and marked. The 
precise genetic and environmental risk factors which lead to the development of chronic 
pain are poorly understood. Although chronic pain may have a single identifiable cause in 
many patients, pain duration and intensity, as well as the physical, psychological and 
social effects of pain, are influenced by a number of other risk factors. The relationship 
between pain and sleep is reported to be reciprocal, with pain affecting sleep quality, 
and sleep disturbance exacerbating pain (1). Patients often find themselves in a vicious 
cycle, with worsening health, wellbeing and quality of life. There is therefore a need to 
identify and treat sleep problems in chronic pain patients. Not only does this have the 
potential to improve patients’ quality of life and functioning, but also to improve pain. 
The extent of the sleep problems we have identified in our patients with chronic non-
malignant pain suggest that intervention to improve sleep may be worthwhile. This may 
take various forms from promotion of sleep hygiene, good pain control to 
pharmacological management including exogenous administration of melatonin (17).   
 
Conclusion 
The aim of this study was to assess the extent and nature of sleep issues in patients with 
chronic pain and to investigate whether the question on sleep interference in the BPI 
could be used as a simple first step to identify sleep problems by investigating whether it 
reflected validated sleep assessment tools. We found that the majority of patients 
attending the pain management clinic had poor sleep quality, high levels of sleep 
disturbance, short sleep duration with marked waking after sleep onset, and poor sleep 
efficiency, all of which were associated with pain severity.  We also found that the BPI 
sleep interference score concurred broadly with the three validated sleep assessment 
tools such that the BPI could be used to routinely monitor sleep problems in the clinic. 
Given the extent of sleep issues in patients with chronic pain, measures to improve sleep 
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Table 1: Baseline Demographic data 
 Total Female Male 
Number (%) 51 37 (72.5) 14 (27.5) 
Age (years) 53 [18-88] 53 [18-88] 52.5 [33-78] 
Chronic pain duration -years 
Median [range] 
6 [1.8-33] 6 [1.8-33] 7 [2-30] 
Chronic pain type – number (%)    
  Neuropathic 10 (19.6) 8 (21.6) 2(14.3) 
  Predominantly neuropathic        5 (9.8) 4 (10.8) 1 (7.1) 
  Nociceptive 11 (21.6) 5 (13.5) 6 (42.9) 
  Predominantly nociceptive 15 (29.4) 11 (29.7) 4 (28.6) 
  Visceral 1 (2.0) 1 (2.7) 0  
  Mixed 9 (17.6) 8 (21.6) 1 (7.1) 
Medication type- number (%)    
  Simple analgesia 23 (45.1) 18 (48.6) 5 (35.7) 
  NSAIDs 22 (43.1) 15 (40.5) 7 (50.0) 
  Compound analgesics 10 (19.6) 7 (18.9) 3 (21.4) 
  Opioids 19 (37.3) 16 (43.2) 3 (21.4) 
  Anticonvulsants 16 (31.4) 10 (27.0) 6 (42.9) 
  Antidepressants 13 (25.5) 13 (35.1) 0  
  Other 26 (51.0) 18 (48.6) 8 (57.1) 




Table 2 Sleep and pain scores 







   Average pain score 















   Total score 















PSQ-3    








VSH    
   Disturbance    
   Efficiency  
   Supplementation   
   WASO   
   Latency  
 
 
413 [36-697] 
234 [98-514] 
13 [0-368] 
44 [0-99] 
58 [0-100] 
 
 
331 [75-598] 
376 [177-458] 
67 [0-368] 
29 [8-99] 
57 [7-101] 
 
 
 
425 [26-690] 
212 [103-515] 
12 [0-177] 
50 [1-92] 
75 [0-100] 
 
